MOLECULAR DIAGNOSTICS: The Key Driver in Personalized Cancer Medicine

R$1.209,60

Fora de estoque

REF: 9974 Categoria:

*** SOLICITE SEU ORÇAMENTO A LIVRARIA BIOTEC – EMAIL.: biotec@livrariabiotec.com.br – CNPJ 07.993.228/0001-79
*** PREÇO SUJEITO A REAJUSTE***

Descrição

This unique book provides a thorough overview of developing molecular cancer diagnostic assays, which are the prerequisites for optimal solutions within personalized cancer medicine. The book takes the reader through definitions of the pharmacodiagnostic concept, historical perspectives of the early steps into molecular cancer diagnostics linked to therapy, the basis of different diagnostic molecular techniques, ongoing research, drug-diagnostic co-development, assay validation, clinical trial methodology, regulatory issues around pharmacodiagnostics and future aspects within personalized cancer medicine
The book is the first of its kind to cover relevant subjects around molecular cancer diagnostics when used as important drivers in personalized cancer medicine. The different chapters of the book are authored by key opinion leaders, each representing their specialized areas, which provide the reader with expertise knowledge in the field
Contents:

Introduction (H Winther & J T Jørgensen)
Developing Molecular Diagnostics in Cancer (H Winther & J T Jørgensen)
The Estrogen & Progesterone Receptors — Setting the Scene for Pharmacodiagnostics (K-L Cheung)
The Development of the HerceptestTM — From Bench to Bedside (J T Jørgensen & H Winther)
Predictive Biomarkers and Translational Cancer Medicine (A-S Schrohl et al)
Pharmacodiagnostic Testing — Immunohistology (A S-Y Leong & T Y-M Leong)
In Situ Hybridisation for Pharmacodiagnostic Testing (J M S Bartlett & F M Campbell)
MammaPrint® Translating Research into a Diagnostic Test (A M Glas et al.)
DNA Biomarkers in the Diagnosis and Management of Cancer (R R Serizawa & P Guldberg)
Validating the Analytical Power and Parameters of an Immunohistochemical Test (C Nielsen)
Drug and Pharmacodiagnostic Co-Development Statistical Considerations (R Simon)
Clinical Validation of Biomarkers in Cancer (S J Mandrekar & D J Sargent)
Pharmacogenomic Markers for Cancer Therapy (S Marsh)
Safety and Effective Biomarkers in Oncology — A Regulatory Drug and Device Perspective (A Rahman & F Kalush)
Personalizing Treatment Selection for Breast Cancer (L Pusztai & C C Yeoh)
Pharmacodiagnostics and Personalized Medicine in Cancer (J T Jørgensen)

Informação adicional

Peso 3 kg
Autor

JORGENSEN

ISBN

9789814241441

ISBN10

981424144X

Editora

PAN STANFORD

Número de Páginas

360 pags.

Idioma

Ingles

Ano

2010